Other Aliphatic rings

• 

  octahydropyrrolo[1,2-a]pyrimidin-4-one

  AD172013856600-42-590%
• 

  tert-butyl 5-oxa-2,9-diazaspiro[3.5]nonane-2-carboxylate

  AD1720112138422-21-490%
• 

  2-(1,4-diazepan-1-yl)-N-methylacetamide dihydrochloride

  AD1719512126177-11-390%
• 

  3-{[2-(diethylamino)ethyl]amino}-1lambda6-thiolane-1,1-dione dihydrochloride

  AD1719332126178-81-090%
• 

  [3-(hydroxymethyl)azetidin-3-yl]methanol hydrochloride

  AD1719281016232-92-090%
• 

  5-ethyl-3,3-dimethylpiperazine-2,6-dione

  AD1719231869175-38-190%
• 

  (1S)-1-(azetidin-3-yl)ethan-1-ol, trifluoroacetic acid

  AD1718932089246-46-690%
• 

  tert-butyl 2-methylmorpholine-2-carboxylate

  AD1718792138347-64-390%
• 

  ethyl 2-methylmorpholine-2-carboxylate hydrochloride

  AD1718722060062-09-990%
• 

  1,3,5,6-tetramethylpiperazin-2-one

  AD1717871934278-94-090%
• 

  3,5,6-trimethylpiperazin-2-one, Mixture of diastereomers

  AD17174984688-49-390%
• 

  6-oxa-2-thia-9-azaspiro[4.5]decane

  AD1717211367994-20-490%
• 

  3-(propan-2-yl)-1,3,7-triazaspiro[4.4]nonane-2,4-dione

  AD1716771423026-28-190%
• 

  3-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]morpholine hydrochloride

  AD1716591461715-10-590%
• 

  3-(methoxymethyl)-3-methylazetidine hydrochloride

  AD1716401622351-29-490%
• 

  2-ethyl-6-methylmorpholine

  AD17161959630-15-890%
• 

  azetidin-3-yl N-(propan-2-yl)carbamate hydrochloride

  AD1715361803601-99-190%
• 

  methyl[3-(pyrrolidin-1-yl)propyl]amine

  AD17149299114-68-890%
• 

  1-(azetidin-3-yl)-3-methylurea hydrochloride

  AD1714861803600-98-790%
• 

  2-(5-methyl-1,3,4-oxadiazol-2-yl)morpholine

  AD1714631509286-40-190%